Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Beekman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|May 9, 2023
Development of Granulomatous Allergic Contact Dermatitis to Hantavirus DNA Gold Particle Vaccine 14 Years After AdministrationKate Beekman, Thomas Beachkofsky, Eugene Sanik, et al.
Physical Medicine and Rehabilitation Clinics of North America|October 10, 2024
Dermatologic Conditions Following Limb LossShaliz Aflatooni, Kate Beekman, Kerry Hennessy, et al.
Annals of Surgical Oncology|July 22, 2023
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?Kristen E Rhodin, Sin-Ho Jung, Kelly Elleson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatitis : Contact, Atopic, Occupational, Drug|May 9, 2023
Development of Granulomatous Allergic Contact Dermatitis to Hantavirus DNA Gold Particle Vaccine 14 Years After AdministrationKate Beekman, Thomas Beachkofsky, Eugene Sanik, et al.
Physical Medicine and Rehabilitation Clinics of North America|October 10, 2024
Dermatologic Conditions Following Limb LossShaliz Aflatooni, Kate Beekman, Kerry Hennessy, et al.
Annals of Surgical Oncology|July 22, 2023
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?Kristen E Rhodin, Sin-Ho Jung, Kelly Elleson, et al.
Pageof 1